Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study

BACKGROUND: Thiazolidinediones are oral diabetes medications that selectively activate peroxisome proliferator-activated receptor gamma and have potent anti-inflammatory properties. While a few studies have found improvements in pulmonary function with exposure to thiazolidinediones, there are no st...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinne, Seppo T, Feemster, Laura C, Collins, Bridget F, Au, David H, Perkins, Mark, Bryson, Christopher L, O’Riordan, Thomas G, Liu, Chuan-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094895/
https://www.ncbi.nlm.nih.gov/pubmed/25024717
http://dx.doi.org/10.1186/1710-1492-10-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094895/
https://www.ncbi.nlm.nih.gov/pubmed/25024717
http://dx.doi.org/10.1186/1710-1492-10-34

Ejemplares similares